Collection of blood, urine, and tissue samples for research on skin conditions

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on collecting blood, urine, and tissue samples from patients diagnosed with cutaneous T-cell lymphoma, eczema, and atopic dermatitis. The samples will be used for various research purposes, including immunologic assays, tumor progression monitoring, and genomic and proteomic studies. The goal is to create a central repository that facilitates ongoing and future research aimed at improving treatment options for these skin conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 or older
* able and willing to provide informed consent
* diagnosed with CTCL
* diagnosed with either atopic dermatitis or eczema

Exclusion Criteria:

* Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record

Where it's running

• University of Pittsburgh Medical Center
  Pittsburgh, Pennsylvania, United States Recruiting

Study contacts

• Principal investigator: Oleg E Akilov, M.D., PhD — University of Pittsburgh
• Study coordinator: Charity L Ruhl, LPN
• Email: ruhlcl@upmc.edu
• Phone: 4126472013

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Digital mindfulness app for teens with eczema

  Teens with moderate to severe eczema try a digital mindfulness app to see if it helps control symptoms and improve quality of life.

  Recruiting at 2 sites Weill Medical College of Cornell University · New York, New York and 1 other locations · NCT07746427

• Camoteskimab in adults with moderate-to-severe atopic dermatitis

  This trial tests different doses of camoteskimab versus placebo to see if it helps adults with moderate-to-severe atopic dermatitis who have not fully responded to standard treatments.

  Recruiting at 31 sites Phase 2 Apollo Therapeutics Ltd · Birmingham, Alabama and 84 other locations · NCT07599813

• Low-sodium diet and salt tablets to see if eczema improves

  This study tests whether a low-sodium diet can lessen eczema symptoms in adults with atopic dermatitis, using a cross-over design with sodium tablets and placebo to see if salt intake changes skin sodium and severity.

  Recruiting at 2 sites Phase 4 University of California, San Francisco · San Francisco, California and 1 other locations · NCT07447063

• Soquelitinib for adults with moderate to severe atopic dermatitis

  This 12-week test gives adults with moderate to severe atopic dermatitis daily soquelitinib or a placebo to see if their skin and itch improve and to track side effects.

  Recruiting Phase 2 Corvus Pharmaceuticals, Inc. · South San Francisco, California · NCT07441395

• GX-03 topical treatment for adults with moderate to severe eczema

  This study will test whether applying GX-03, a topical emollient, twice daily for 8 weeks reduces eczema severity and itch in adults with moderate to severe atopic dermatitis compared with a petrolatum-based vehicle.

  Recruiting Phase 2/3 Turn Therapeutics · Irving, Texas · NCT07355075

• Non-Invasive Skin Fluid Biomarkers in Babies with and without Eczema

  This study tests whether a tiny, painless device can safely collect skin interstitial fluid from babies to see if eczema changes immune signals compared with healthy babies.

  Recruiting King's College London · London · NCT07228962

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.